MCX-SX, the third stock exchange after widely known BSE and NSE, had a muted debut. There was some technical problem since initial trade today, as a result participants could not able to see their trades.
In an interview to CNBC-TV 18 Aashish Tater, Head of Research, Fortunewizard.com is bullish on Pharma sector. He discusses Glenmark and Cipla which are a buy for atleast a period of 12-18 months.